Updated analysis of MCLA-128 (zenocutuzumab), trastuzumab, and vinorelbine in patients (pts) with HER2 positive/amplified (HER2+) metastatic breast cancer (MBC) who progressed on previous anti-HER2 ADCsErika Hamilton,Thierry Petit,Barbara Pistilli,Anthony Goncalves, Ana Alexandra Ferreira,Florence Dalenc,Fatima Cardoso,Monica M. Mita,Luis Manso, Syed M. Karim,Francois-Clement Bidard,Philippe Aftimos, Santiago Escrivaa-de-Romanii,Noemia Afonso,Ernesto Wasserman,Kees Bol,Viktoriya Stalbovskaya,Anastasia Vliet,Anastasia Murat,Mohamed Bekradda,Thomas BachelotCANCER RESEARCH（2022）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
